文献速递泌尿生殖妇产影像CTMR

卵巢癌的影像组学与影像基因组学:文献综述

Radiomics and radiogenomics in ovarian cancer: a literature review.
PubMed 文献 · Abdom Radiol (NY) · 2020-11-11

综述概述影像组学、影像基因组学与蛋白质组学,探讨这些新兴领域在评估卵巢癌肿瘤异质性中的应用及意义。文章指出标准CT或MRI评估未考虑肿瘤异质性,尤其晚期腹膜癌病;影像组学可评估整体肿瘤负荷异质性而非单次活检取样。

要点

  • 标准CT或MRI评估未考虑卵巢癌的肿瘤异质性,尤其在晚期腹膜癌病中。
  • 影像组学可评估整体肿瘤负荷异质性,而非依赖单次活检取样。
  • 综述涵盖影像组学、影像基因组学与蛋白质组学在卵巢癌中的应用。

核心结论

  • 影像组学、影像基因组学与蛋白质组学是评估肿瘤异质性的新兴领域,可能对卵巢癌的异质性评估及治疗反应和预后判断有重要意义。

研究设计与样本

  • 文献综述,未报告系统检索范围与纳入文献数量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Ovarian cancer remains one of the most lethal gynecological cancers in the world despite extensive progress in the areas of chemotherapy and surgery. Many studies have postulated that this is because of the profound heterogeneity that underpins response to therapy and prognosis. Standard imaging evaluation using CT or MRI does not take into account this tumoral heterogeneity especially in advanced stages with peritoneal carcinomatosis. As such, newly emergent fields in the assessment of tumor heterogeneity have been proposed using radiomics to evaluate the whole tumor burden heterogeneity as opposed to single biopsy sampling. This review provides an overview of radiomics, radiogenomics, and proteomics and examines the use of these newly emergent fields in assessing tumor heterogeneity and its implications in ovarian cancer.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Nougaret S, McCague C, Tibermacine H, et al. Radiomics and radiogenomics in ovarian cancer: a literature review. Abdom Radiol (NY). 2020. PMID: 33174120. doi:10.1007/s00261-020-02820-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。